U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07055165) titled 'Connect2Care: Prostate Cancer Education and Screenings for African American Men' on June 13.
Brief Summary: Prostate cancer is the most diagnosed cancer in African American men and the second-leading cause of cancer-related death. The prostate-specific antigen (PSA) test is an early detection screening tool for prostate cancer, however, knowledge about prostate cancer and screening benefits and risks and uptake of PSA screening remains low among African American men. To address this inequity, this project proposes the use of the Connect2Care App to improve knowledge of prostate cancer, screening benefits, risks and increase readiness...